Prévenir les complications cardiovasculaires dans les rhumatismes inflammatoires chroniques

Abstract

Cardiovascular disease is the main comorbidity of chronic inflammatory rheumatisms. This increase in prevalence is directly related to systemic inflammation, which increases athematosis processes, but also to the high prevalence of cardiovascular risk factors associated with chronic inflammatory rheumatisms. The rheumatologist has a central role in the management of patients with chronic inflammatory rheumatism and has to know how to assess the cardiovascular risk, to choose the most adapted disease modifying anti-rheumatic drug, to limit the use of long-term NSAIDs and to initiate corticosteroid withdrawal. He should be able to give lifestyle advices, adapted to the level of risk and the capacities of the patients and refer to the specialist high cardiovascular risk patients.